NousCom

ID: 7699522

NousCom is a viral vector-based cancer vaccines developer founded in 2015.

Funding Rounds

$120.5m

Money raised

Recent Funding Rounds

Series B $46.0M Nov 2017 Series B $48.5M Nov 2017 Series A $13.0M May 2016

Overview

NousCom is a viral vector-based cancer vaccines developer founded in 2015.

Website:
- http://www.nouscom.com/
Business model: B2C
Headquarters: Basel
Social accounts: linkedin

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

• Complete funding history and valuations
• Revenue estimates and financial metrics
• Investment round details and terms

People & Contacts

• Complete leadership team profiles
• Contact information and email addresses
• Board members and advisors

Market Intelligence

• Competitive landscape analysis
• Market position and growth metrics
• Industry benchmarking data

Premium Tools

• Export data and generate reports
• Save companies to custom watchlists
• API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

View Membership Plans Contact Sales

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company NousCom has raised a total of $120.5m in funding over 4 rounds.

Key Insights:

Nouscom November 2017 Series B Funding Round: $46m
NousCom Series B round, November 2017: $48.5m
Nouscom May 2016 Series A Funding Round: $13m
Nouscom May 2016 Series A Funding Round: $13m

2017

Nouscom November 2017 Series B Funding Round $46m